This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: University of Cincinnati, The General Hospital Corporation. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 556 
3 out of 3,073 
Years Active: 2011-2025
Title: Evangelia Kranias: Innovator in Cardiac Research
Introduction
Evangelia Kranias is a prominent inventor based in Cincinnati, OH, known for her significant contributions to cardiac research. With a total of five patents to her name, she has made remarkable strides in understanding and treating cardiac disorders.
Latest Patents
Her latest patents focus on modulating phosphatase activity in cardiac cells. One of her key inventions involves the expression of a phosphatase inhibitor in heart cells, which can be utilized to treat cardiac disorders such as heart failure. By decreasing phosphatase activity, her research indicates that it is possible to improve β-adrenergic responsiveness, offering new avenues for treatment.
Career Highlights
Throughout her career, Kranias has worked with esteemed institutions, including the University of Cincinnati and The General Hospital Corporation. Her work has been pivotal in advancing the field of cardiac health and has garnered attention for its innovative approach.
Collaborations
Some of her notable coworkers include Roger J. Hajjar and Federica Del Monte, who have collaborated with her on various research projects.
Conclusion
Evangelia Kranias stands out as a leading inventor in the field of cardiac research, with her patents paving the way for potential breakthroughs in treating heart conditions. Her dedication to innovation continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile